Based on 1 Customer Validation
Exatecan mesylate (DX8951f ) GMP is a GMP-class Exatecan (HY-13631). Exatecan is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 169869-90-3
- 화학식: C25H26FN3O7S
- 분자량:531.55
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- 순도&문서
- References
-
Help & FAQs
-
HY-13631AS
Exatecan-d5 mesylateStable Isotope -
HY-13631A
Exatecan mesylateTopoisomerase I Inhibitor -
HY-13631R
Exatecan (Standard)Topoisomerase I Inhibitor -
HY-13727A
PixantroneTopoisomerase II Inhibitor -
HY-13631
ExatecanTopoisomerase I Inhibitor -
HY-N0095
(S)-10-HydroxycamptothecinTopoisomerase I Inhibito -
HY-100309
9-AminocamptothecinTopoisomerase I Inhibitor -
HY-13744
RubitecanTopoisomerase Inhibitor -
HY-15753
EllipticineTopoisomerase Inhibitor -
HY-16228
Genz-644282 -
HY-13566A
Belotecan hydrochlorideTopoisomerase Inhibitor -
HY-13631D
DXdTopoisomerase I Inhibitor
All Topoisomerase Isoforms
More
Biological Activity
제품 설명
IC50 & Target
|
Camptothecins |
In Vitro
Exatecan mesylate is only two-fold resistant to PC-6/SN2-5 (SN-38 resistant cell line)[1].
Exatecan mesylate (10 μM, 30 min) has little difference in the accumulation of PC-6 and PC-6/SN2-5 cells[1].
Exatecan mesylate inhibits tumor growth, with the average GI50 values of 2.02, 2.92, 1.53 and 0.877 ng/mL for breast cancer, colon cancer, gastric cancer, and lung cancer cell lines[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BxPC-3-GFP and MIA-PaCa-2GFP orthotopic implantation mouse model[3]
-
Dosage:15-25 mg/kg; once a week; three weeks
-
Administration:Intravenous injection (i.v.)
-
Result:Significantly inhibited primary tumor growth in MIA-PaCa-2 and BxPC-3, and also significantly reduced lymph node metastasis and completely prevented lung metastasis in the BxPC-3 advanced cancer model.
Chemical Information
-
CAS No. 169869-90-3
-
Appearance Solid
-
분자량 531.55
-
화학식 C25H26FN3O7S
-
Color Light yellow to yellow
-
SMILES
O=S(C)(O)=O.O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=C5C6=C(CC[C@@H]5N)C(C)=C(F)C=C6N=C4C3=C2)=O
-
Synonyms
DX8951f (GMP)
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
-
Data Sheet (279 KB)
-
SDS (643 KB)
- English - EN (643 KB)
- Français - FR (643 KB)
- Deutsch - DE (643 KB)
- Norwegian - NO (643 KB)
- Español - ES (643 KB)
- Swedish - SV (643 KB)
- Italian - IT (643 KB)
- Korean - KR (643 KB)
- Portuguese - PT (643 KB)
-
Handling Instructions (2659 KB)
References
[1]. Mitsui I, et al. A new water-soluble camptothecin derivative, DX-8951f, exhibits potent antitumor activity against human tumors in vitro and in vivo. Jpn J Cancer Res. 1995 Aug;86(8):776-82. [Content Brief]
[2]. Sun FX, et al. Efficacy of camptothecin analog DX-8951f (Exatecan Mesylate) on human pancreatic cancer in an orthotopic metastatic model. Cancer Res. 2003 Jan 1;63(1):80-5. [Content Brief]
[3]. Joto N, et al. DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant. Int J Cancer. 1997 Aug 7;72(4):680-6. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Exatecan mesylate (GMP) Related Classifications
HY-13631AG Related Classifications
Powered by Bioz